Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/87107
Title: Catalytic asymmetric acetalization of carboxylic acids for access to chiral phthalidyl ester prodrugs
Authors: Liu, Yingguo
Chen, Qiao
Mou, Chengli
Pan, Lutai
Duan, Xiaoyong
Chen, Xingkuan
Chen, Hongzhong
Zhao, Yanli
Lu, Yunpeng
Jin, Zhichao
Chi, Robin Yonggui
Keywords: Asymmetric Catalysis
Drug Discovery and Development
Science::Chemistry
Issue Date: 2019
Source: Liu, Y., Chen, Q., Mou, C., Pan, L., Duan, X., Chen, X., . . . Chi, R. Y. (2019). Catalytic asymmetric acetalization of carboxylic acids for access to chiral phthalidyl ester prodrugs. Nature Communications, 10(1), 1675-. doi:10.1038/s41467-019-09445-x
Series/Report no.: Nature Communications
Abstract: Carboxylic acids are common moieties in medicines. They can be converted to phthalidyl esters as prodrugs. Unfortunately, phthalidyl esters are now mostly prepared in racemic forms. This is not desirable because the two enantiomers of phthalidyl esters likely have different pharmacological effects. Here we address the synthetic challenges in enantioselective modification of carboxylic acids via asymmetric acetalizations. The key reaction step involves asymmetric addition of a carboxylic acid to the catalyst-bound intermediate. This addition step enantioselectively constructs a chiral acetal unit that lead to optically enriched phthalidyl esters. A broad range of carboxylic acids react effectively under mild and transition metal-free conditions. Preliminary bioactivity studies show that the two enantiomers of chlorambucil phthalidyl esters exhibit different anti-cancer activities to inhibit the growth of Hela cells. Our catalytic strategy of asymmetric acetalizations of carboxylic acids shall benefit future development of chiral phthalidyl ester prodrugs and related molecules.
URI: https://hdl.handle.net/10356/87107
http://hdl.handle.net/10220/49866
DOI: http://dx.doi.org/10.1038/s41467-019-09445-x
Rights: © 2019 The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SPMS Journal Articles

Google ScholarTM

Check

Altmetric

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.